All posts in fetal cardiology

Diagnosis, characterization and outcome of ccTGA

Diagnosis, characterization and outcome of congenitally
corrected transposition of the great arteries in the fetus:
a multicenter series of 30 cases
D. PALADINI*, P. VOLPE†, M. MARASINI‡, M. G. RUSSO§, M. VASSALLO*, M. GENTILE¶,and R. CALABR ` O§
*Fetal Cardiology Unit, Department of Gynecology and Obstetrics, University Federico II of Naples and §Department of Pediatric Cardiology, 2nd University of Naples, Monaldi Hospital, Naples, †Department of Obstetrics and Gynecology, ‘‘Di Venere-Giovanni XXIII’’ Hospital and ¶Department of Medical Genetics, I.R.C.C.S. ‘‘Di Venere-Giovanni XXIII’’ Hospital, Bari and ‡Pediatric Cardiology,
I.R.C.C.S. Giannina Gaslini Hospital, Genoa, Italy

Congenitally corrected transposition of the great arteries
(ccTGA) is characterized by atrioventricular and ventriculoarterial discordance. It represents a rare cardiac
defect, accounting for 1.1% of cases of major congenital
heart disease (CHD), and has an incidence at birth of
0.02 per 1000 live births. Prenatal diagnosis of this
lesion is feasible but may be difficult to detect at routine
screening because the atrioventricular discordance may
be overlooked if other significant anomalies of the fourchamber
view are absent.

Share Button
More

Familial Origin of Atrial Septal Aneurysm

Familial Origin of Atrial Septal Aneurysm
Ioannis A. Paraskevaidis, MDa,b,*, Dimitrios Tsiapras, MDa, Stamatis Kyrzopoulos, MDa,
and Dimitrios T. Kremastinos, MDb


The familial origin of atrial septal defects has been previously reported.
This is the first study describing 2 families with atrial septal aneurysm of familial origin.

Share Button
More

Williams-Beuren syndrome (WBS)

Williams-Beuren syndrome (WBS) is a multisystem genetic disorder caused by a microdeletion on chromosome 7. The majority of patients demonstrate cardiovascular pathology, most commonly supravalvular aortic and/or other vascular stenoses……………

Share Button
More

Workshop on Magnetic Resonance on CHD

2nd Workshop on :

Magnetic Resonance Imaging in Diagnosis and Management of Congenital Heart Disease
21-22 october 2005 – Massa

Share Button
More

Quantitative Assessment of Fetal Ventricular Function

Quantitative Assessment of Fetal Ventricular Function:
Establishing Normal Values of the Myocardial Performance Index in the Fetus
Benjamin W. Eidem, M.D., Jeanette M. Edwards, M.D., and Frank Cetta, M.D.
Department of Pediatrics, Section of Pediatric Cardiology, Loyola University Medical Center,
Maywood, Illinois

Share Button
More

2D and 3D Ultrasound in the Evaluation of Normal and Abnormal Fetal Anatomy

Ultraschall Med 2005 26(1):9-16

2D and 3D Ultrasound in the Evaluation of Normal and Abnormal Fetal Anatomy in the Second and Third Trimesters in a Level III Center.

Merz E, Welter

Share Button
More

Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome).

Digilio MC,1 Marino B,2 Capolino R,1 Dallapiccola B.3 Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome). Images Paediatr Cardiol 2005;23:23-34
1 Medical Genetics, Bambino Gesù Hospital, Rome, Italy
2 Pediatric Cardiology, Institute of Pediatrics, University “La Sapienza”, Rome, Italy
3 Experimental Medicine and Pathology, University “La Sapienza”, and CSS-Mendel Institute, Rome, Italy

Abstract
Deletion 22q11.2 syndrome (Del22) (DiGeorge/Velo-Cardio-Facial syndrome) is characterized by congenital heart defect (CHD), palatal anomalies, facial dysmorphisms, neonatal hypocalcemia, immune deficit, speech and learning disabilities. CHD is present in 75% of patients with Del22.

Share Button
More

Ultrasonic Biophysical Measurements in the Normal Human Fetus for Optimal Design of the Monolithic Fetal Pacemaker

Ultrasonic Biophysical Measurements in the Normal Human Fetus for Optimal Design of the Monolithic
Fetal Pacemaker
Evgueni Fayn, MD, Howard A. Chou, PhD, DaeGyun Park, MD, PhD, Daniel H. Zavitz, MSc, Bettina F. Cuneo, MD, Vicki L. Mahan, MD, Mehmet Guleçyuz, MD, Letitia Curran, RDMS, David Lipson, PhD,
Edmond W. Quillen, Jr., PhD, Boris M. Petrikovsky, MD, PhD, and Marc Ovadia, MD

The failures of current medical therapeutics for the management of fetal complete atrioventricular
block with hydrops fetalis, as well as the increasing number of fetuses at risk for acute bradycardia during interventional procedures and fetal surgeries, have inspired the author of this article to develop a monolithic pacemaker designed for closed-thorax, closed-uterus, closed–maternal abdomen over-the-wire deployment under ultrasound guidance.

Share Button
More